Clinical trials
Alcohol clinical trials
Below are recruiting alcohol clinical trials, each written for real people, not researchers. We’re tracking 561 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06508190Recruiting
Walking exercise for sleep apnea and fatty liver
This trial tests whether a simple walking program can help people who have both obstructive sleep apnea and non-alcoholic fatty liver disease. If you have these conditions and a BMI under 35, you may be able to join a free exercise program to see if it improves your health.
GizaAges 40–65 - NCT06512389RecruitingPhase 2
Testing CBD for alcohol cravings
This study tests whether a medication called cannabidiol (CBD) can help reduce cravings for alcohol. Over several weeks, you will take the study pill and attend lab sessions where you can choose to drink alcohol in a safe setting.
Toronto, OntarioAges 19 years+ - NCT06512701Recruiting
Fat-soluble vitamins and fatty liver disease study
This study looks at how fat-soluble vitamins (like vitamins A, D, E, and K) are related to non-alcoholic fatty liver disease (NAFLD). It may help understand if vitamin levels affect your liver health.
Hangzhou, ZhejiangAges 18 years+ - NCT06513819RecruitingPhase 1
HIV and Alcohol Study for People on Multiple Medications
This study looks at how alcohol use affects people with HIV who take multiple medications, including certain brain or nerve drugs. It aims to find safer ways to manage their health.
West Haven, ConnecticutAges 50 years+ - NCT06518785Recruiting
Ultrasound brain treatment for alcohol use disorder
This study tests if focused ultrasound can help reduce alcohol cravings by stimulating a specific part of the brain. Participants will receive ultrasound treatments and undergo an MRI to see how the brain responds.
San Francisco, CaliforniaAges 18 years+ - NCT06569524RecruitingPhase 2
A new drug for NASH with liver scarring
This study tests a new injected drug (TQA2225/AP025) that may help reduce liver fat and inflammation in people with NASH (a type of fatty liver disease with scarring). It’s for adults who have had a recent liver biopsy and MRI confirming NASH and moderate liver fat.
Lu'an, AnhuiAges 18–75 - NCT06618755Recruiting
Staying sober after detox: a coaching study
This study tests if motivational interviews after hospital detox help people with alcohol use disorder stay completely sober for one year. It might help you if you are committed to full abstinence and have a phone available.
MontpellierAges 18 years+ - NCT06620276Recruiting
Ketamine and therapy for alcohol use disorder and depression
This trial tests if combining ketamine infusions with weekly therapy can help people who have both alcohol use disorder and hard-to-treat depression. You may qualify if you drink at least moderately, have treatment-resistant depression, and are willing to attend 8 therapy sessions.
Montreal, QuebecAges 18–70 - NCT06629259RecruitingPhase 2
Guanfacine for Alcohol Use Disorder
This trial tests if guanfacine, a medication that calms certain brain signals, can help people reduce or stop drinking. You may qualify if you have moderate to severe alcohol use disorder and want to quit.
Indianapolis, IndianaAges 18 years+ - NCT06636227RecruitingPhase 1
Diclofenac dose study for alcohol use disorder
This study tests whether different doses of diclofenac, an anti-inflammatory drug, can help people reduce heavy drinking. It looks at how the drug affects drinking patterns and overall health.
Catonsville, MarylandAges 21–65 - NCT06648642Recruiting
MRI-guided brain stimulation for alcohol use disorder
This study tests whether a new type of brain stimulation, guided by MRI and a robot, can help reduce heavy drinking in people with alcohol use disorder. The treatment is non-invasive and aims to improve brain function related to cravings.
San Antonio, TexasAges 18–65 - NCT06676813Recruiting
Fasting every other day for fatty liver disease
This study tests whether fasting every other day (alternate day fasting) can help reverse fatty liver disease (NASH/MASH) when added to standard medical care. It is for people with fatty liver and some liver scarring, who are not on weight loss medications and do not have diabetes that is poorly controlled.
DelhiAges 18–65 - NCT06679062RecruitingPhase 2
Suvorexant for alcohol use disorder and PTSD
This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.
Los Angeles, CaliforniaAges 21–65 - NCT06701487Recruiting
Brain learning mechanisms and substance use control
This study looks at how certain learning mechanisms in the brain (called Pavlovian conditioning) influence your ability to control alcohol or drug use. It may help explain why some people have trouble stopping, and could lead to better treatments. You'll fill out questionnaires and likely have a brain scan (MRI).
DresdenAges 18–65 - NCT06702007RecruitingPhase 3
E-help for reducing alcohol harm
This study tests a program that helps reduce harm from drinking for people in Housing First. It uses electronic tools and support to help you cut back safely.
Seattle, WashingtonAges 21 years+ - NCT06706349Recruiting
Exercise to improve sleep in alcohol use disorder
This study tests whether a personalized exercise program can improve sleep quality in people with alcohol use disorder. You would work with a physical activity coach over several weeks, and your sleep and health would be monitored closely.
BesançonAges 18–65 - NCT06740318Recruiting
Reversing liver damage in alcohol-related hepatitis
This trial studies whether people with alcohol-related hepatitis can see their liver function improve. It looks at patients whose diagnosis is supported by blood tests and imaging, and excludes those with liver cancer.
HvidovreAges 18 years+ - NCT06747364Recruiting
Blood test for recent alcohol use
This study looks at a blood test that may tell how much alcohol a person has had recently, even after they've stopped drinking. It may help doctors better understand drinking patterns and health risks.
Denton, TexasAges 21 years+ - NCT06787235Recruiting
Can a special diet help reduce alcohol intake?
This study tests whether a nutritional program (a modified ketogenic diet) can help people with alcohol use disorder reduce their drinking. It aims to find out if changing what you eat can support your goals around alcohol.
BernAges 18–80 - NCT06795581RecruitingPhase 1
Brain imaging study for alcohol use disorder
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.
Bethesda, MarylandAges 18–70 - NCT06835907Recruiting
Baclofen for anxiety and alcohol use disorder
This trial tests if baclofen can help people with both anxiety and alcohol use disorder. It is an open-label study, meaning everyone knows they are taking the medication. Researchers want to see if it supports people in staying alcohol-free.
Jette, Brussels CapitalAges 18–65 - NCT06847165Recruiting
Trigeminal nerve stimulation for kids with prenatal alcohol exposure
This study tests a gentle, non-invasive nerve stimulation device to see if it can improve attention and behavior in children aged 8-12 who were exposed to alcohol before birth and have ADHD. If it helps, it could offer a new way to manage symptoms without medication.
Los Angeles, CaliforniaAges 8–12 - NCT06850428Recruiting
Alcohol recovery, sleep patterns, and activity levels
This study looks at how physical activity and your natural sleep-wake patterns (chronotype) relate to recovery from alcohol dependence. If you’re in remission and not currently drinking, researchers want to see how these factors affect your well-being.
Ankara, KeçiörenAges 18–65 - NCT06856161Recruiting
Blood test to help diagnose mental health conditions
This study is testing a new blood test that might help doctors better understand and diagnose conditions like depression, psychosis, or schizophrenia. If you are 19 or older and have one of these conditions, you may be able to join.
New Westminster, British ColumbiaAges 19 years+
Hear when a new Alcohol trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alcohol?
- Yes. Clin2 currently lists 561 recruiting alcohol studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alcohol trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alcohol trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.